Replay available

Chemours Company (The) (CC) Q1 2025 Earnings Call

Chemours Company (The) (NYSE: CC) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.

Wed, May 7, 2025 at 8:00 AMendedReplay
Chemours Company (The) (CC) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Denise Dignam

President and Chief Executive Officer

Shane Hostetter

Senior Vice President and Chief Financial Officer

John McNulty

BMO Analyst

John Roberts

Mizuho Analyst

Pete Osterlin

Truist Analyst

Lawrence Alexander

Research Analyst

Arun Viswanathan

RBC Capital Analyst

Josh Spector

UBS Analyst

Duffy Fisher

Goldman Sachs Analyst

Vincent Andrews

Morgan Stanley Analyst

Mike Lighthead

Barclays Analyst

Replay transcript excerpt

Good morning, my name is Michelle and I will be your conference operator today. I would like to welcome everyone to the Chemours Company first quarter full year 2025 results conference call. Currently all participants are in the listen only mode. A question and answer session will follow the conclusion of the prepared remarks. I would like to remind everyone that this conference call is being recorded. I would now like to hand the conference over to Brandon on just Vice President, Head of Strategy and Investor Relations for Chemours. You may begin your call. Good morning, everybody. Welcome to the Chemours Company's first quarter 2025 earnings conference call. I'm joined today by Denise Dignam, Chemours' President and Chief Executive Officer, and our Senior Vice President and Chief Financial Officer, Shane Hostetter. Before we start, I would like to remind you that comments made on this call, as well as in the supplemental information provided on our website, contain forward-looking statements that involve risks and uncertainties as described in CMORS' SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events that may not be realized. Actual results may differ, and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information. During the course of this call, we will refer to certain non-GAAP financial measures that we believe are useful to investors evaluating the company's performance. A reconciliation of non-GAAP terms and adjustments is included in our press release issued yesterday evening. Also, we posted our earnings presentation to our website yesterday as well. With that, I will turn the call over to ...

More from Chemours Company (the)